For New York patients living with treatment-resistant Depression (TRD), new therapies can feel like rays of hope breaking through the darkness. The highly publicized clinical trial of psilocybin in the
An Update on Finding Depression Relief With TMS
Depression can be overwhelming, especially when traditional medications or therapy have not provided the relief you need. If you are a New York City resident who has struggled with treatment-resistant
Non-Invasive Depression Treatment Options NYC: TMS Avoids Antidepressant Side Effects
Living with Depression in New York City can feel overwhelming. Between the fast pace, constant noise, and high demands of daily life, the burden of untreated or poorly treated Depression
Combatting a Low Rate of Long-Term Antidepressant Success with TMS Therapy
For decades, antidepressant medications have been the first-line treatment for major depressive disorder (MDD). While they have helped millions of people, the reality is that they often fall short—with new
Beyond Antidepressants: Why TMS May Be the Best Next Step in Battling Symptoms of Depression in Older Adults
For many older adults, Depression is more than just sadness. It can be persistent, debilitating, and resistant to standard treatment. In fact, a significant number of adults over the age
Breaking the Cycle of Treatment-Resistant Depression: Real-World Lessons from Europe
Treatment-resistant Depression (TRD) poses a significant challenge in mental health care. Despite the availability of various antidepressant therapies, a substantial subset of patients fails to achieve response or remission, leading
Enhancing Depression Treatment: The Synergistic Potential of TMS and Antidepressants
Major Depressive Disorder (MDD) stands as a leading cause of disability worldwide, affecting millions and imposing significant personal and societal burdens. Traditional treatment modalities, primarily pharmacotherapy with antidepressants, have shown
Comparing TMS With Other Antidepressant Treatments
In the evolving landscape of mental health treatments, finding effective solutions for treatment-resistant Depression (TRD) remains a significant challenge. As many as one third of patients with major depressive disorder